DK279890A - Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer - Google Patents

Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer Download PDF

Info

Publication number
DK279890A
DK279890A DK279890A DK279890A DK279890A DK 279890 A DK279890 A DK 279890A DK 279890 A DK279890 A DK 279890A DK 279890 A DK279890 A DK 279890A DK 279890 A DK279890 A DK 279890A
Authority
DK
Denmark
Prior art keywords
caloids
vincal
liposom
encouraged
medicine
Prior art date
Application number
DK279890A
Other languages
English (en)
Other versions
DK175869B1 (da
DK279890D0 (da
Inventor
Aquilur Rahman
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of DK279890A publication Critical patent/DK279890A/da
Publication of DK279890D0 publication Critical patent/DK279890D0/da
Application granted granted Critical
Publication of DK175869B1 publication Critical patent/DK175869B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199002798A 1988-05-23 1990-11-23 Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et lægemiddel til bekæmpelse af tumorer DK175869B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/197,648 US4952408A (en) 1988-05-23 1988-05-23 Liposome-encapsulated vinca alkaloids and their use in combatting tumors
US19764888 1988-05-23
US8902173 1989-05-23
PCT/US1989/002173 WO1989011292A1 (en) 1988-05-23 1989-05-23 Liposome-encapsulated vinca alkoaloids and their use in combatting tumors

Publications (3)

Publication Number Publication Date
DK279890A true DK279890A (da) 1990-11-23
DK279890D0 DK279890D0 (da) 1990-11-23
DK175869B1 DK175869B1 (da) 2005-04-25

Family

ID=22730210

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199002798A DK175869B1 (da) 1988-05-23 1990-11-23 Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et lægemiddel til bekæmpelse af tumorer

Country Status (9)

Country Link
US (1) US4952408A (da)
EP (1) EP0416014B1 (da)
JP (1) JPH03504381A (da)
AU (1) AU625308B2 (da)
CA (1) CA1339077C (da)
DE (1) DE68914154T2 (da)
DK (1) DK175869B1 (da)
IE (1) IE64513B1 (da)
WO (1) WO1989011292A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194767T1 (de) * 1992-03-23 2000-08-15 Univ Georgetown In liposomen verkapseltes taxol und verwendungsverfahren
GB9211659D0 (en) * 1992-06-02 1992-07-15 Indena Spa New alkaloid derivatives,their use and pharmaceutical formulations containing them
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5741516A (en) * 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US6107102A (en) * 1995-06-07 2000-08-22 Regents Of The University Of California Therapeutic microdevices and methods of making and using same
US6447800B2 (en) 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
WO2000059473A1 (en) * 1999-04-01 2000-10-12 Inex Pharmaceuticals Corp. Compositions and methods for treating lymphoma
US7311924B2 (en) * 1999-04-01 2007-12-25 Hana Biosciences, Inc. Compositions and methods for treating cancer
US6723338B1 (en) * 1999-04-01 2004-04-20 Inex Pharmaceuticals Corporation Compositions and methods for treating lymphoma
US7244450B2 (en) * 1999-04-01 2007-07-17 Inex Pharmaceuticals Corporation Compositions and methods for treating lymphoma
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1355634B8 (en) 2000-11-09 2009-03-04 Neopharm, Inc. Sn-38 lipid complexes and methods of use
US20030082228A1 (en) * 2001-05-09 2003-05-01 Inex Pharmaceuticals Corporation Anti-angiogenic therapy using liposome-encapsulated chemotherapeutic agents
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
WO2003018018A2 (en) * 2001-08-24 2003-03-06 Neopharm, Inc. Vinorelbine compositions and methods of use
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
WO2004035032A2 (en) * 2002-08-20 2004-04-29 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
AU2003268087A1 (en) * 2002-08-23 2004-03-11 Ian Ma Liposomal gemcitabine compositions for better drug delivery
BRPI0407096A (pt) * 2003-02-03 2006-01-24 Neopharm Inc Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20090285878A1 (en) * 2004-11-05 2009-11-19 Tekmira Pharmaceuticals Corporation Compositions and methods for stabilizing liposomal drug formulations
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2009059449A1 (en) * 2007-11-05 2009-05-14 Celsion Corporation Novel thermosensitive liposomes containing therapeutic agents
MX2015005992A (es) 2012-11-20 2016-03-07 Spectrum Pharmaceuticals Inc Metodo mejorado para la preparacion de la vincristina liposomal encapsulada para el uso terapeutico.
TWI678213B (zh) 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479957A (en) * 1973-04-02 1984-10-30 Eli Lilly And Company Use of vindesine in treating acute lymphatic leukemia and _other susceptible neoplasms
US4117113A (en) * 1974-06-25 1978-09-26 National Research Development Corporation Immunological preparations
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4362664A (en) * 1980-12-29 1982-12-07 Eli Lilly And Company Vinblastine oxazolidinedione disulfides and related compounds
JPS5841814A (ja) * 1981-08-10 1983-03-11 ザ・ウエルカム・フアウンデ−シヨン・リミテツド 抗レ−シユマニア症薬剤組成物およびその製造法
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4663167A (en) * 1984-04-16 1987-05-05 The Board Of Regents Of The University Of Texas System Composition and method for treatment of disseminated fungal infections in mammals
CA1270198C (en) * 1984-08-08 1990-06-12 Marcel B Bally ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
US4771782A (en) * 1986-11-14 1988-09-20 Millar Instruments, Inc. Method and assembly for introducing multiple catheters into a biological vessel

Also Published As

Publication number Publication date
CA1339077C (en) 1997-07-29
DK175869B1 (da) 2005-04-25
US4952408A (en) 1990-08-28
AU3742489A (en) 1989-12-12
AU625308B2 (en) 1992-07-09
DE68914154T2 (de) 1994-10-20
WO1989011292A1 (en) 1989-11-30
EP0416014A4 (en) 1991-08-14
IE64513B1 (en) 1995-08-09
JPH03504381A (ja) 1991-09-26
DE68914154D1 (de) 1994-04-28
EP0416014A1 (en) 1991-03-13
IE891661L (en) 1989-11-23
DK279890D0 (da) 1990-11-23
EP0416014B1 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
DK279890D0 (da) Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer
DK674389D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af artritiske og inflammatoriske sygdomme
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK551187A (da) Terapeutisk praeparat og dettes fremstilling
DK177690D0 (da) Behandling af fedme
DK272389D0 (da) Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK95489D0 (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK141090A (da) Fremstilling af human prourokinase
FI894321A7 (fi) Terapeuttisia aineita
DK143488D0 (da) Laegemiddel til behandling af cancer
DK221689D0 (da) Naturstensplade og fremgangsmaade til fremstilling af naturstensplade
DK0390762T3 (da) Hidtil ukendte bronchospasmolytiske forbindelser og fremgangsmåde til fremstilling heraf
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK429589A (da) Transdermalt laegemiddelpraeparat
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK13989D0 (da) Anvendelse af tnf og lt til fremstilling af laegemidler.
DK681288D0 (da) Aenootropt terapeutisk laegemiddelae
DK641189A (da) Praeparat til behandling af glaucom og fremgangsmaade til fremstilling af et saadant praeparat
KR900011608U (ko) 치료용 복대
DK469487D0 (da) Laegemiddel til behandling af fedme

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK